2023.Apr.20
Corporate
Poster Presentations at AACR 2023 Annual Meeting for OBI-999 combination synergy with checkpoint inhibitor as well as Globo H-targeted CAR T-cell immunotherapy
Title: OBI-999, an anti-Globo H antibody drug conjugate, exhibits synergistic anti-tumor effect in combination with pembrolizumab Abstract number: 5946 / Poster number: 5946/7 Title: Globo H-targeted CAR T cell cancer immunotherapy Abstract number: 4084 / Poster Number: 4084/3
This article is password protected.
To view the content, please enter your password in the field below